Sponsored Symposia: Chronic Antibody-Mediated Rejection Sponsored by CSL Behring

Originally presented at the AST Cutting Edge of Transplantation (CEoT) Meeting in February 2021, this rebroadcasted session focuses on chronic antibody mediated rejection (CAMR), an increasingly recognized common post-transplant complication that reduces kidney transplant allograft legevity. Thought leaders and researchers in the field will provide an overview of chronic antibody mediated rejection and its impacts on allograft survival as well as exciting updates on new diagnostics as well as treatment strategies to address it.

This is not an official function of the CEoT Meeting and is not endorsed by the AST.

Video will be posted on the AST's Youtube Channel, be sure to subscribe to watch at your convenience.